Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00928 | Azacitidine | 1 / 2 | Completed | 1 |
| DB00515 | Cisplatin | 1 / 2 | Completed | 1 |
| DB00441 | Gemcitabine | 1 / 2 | Completed | 1 |
| DB09035 | Nivolumab | 1 / 2 | Completed | 1 |
| DB16267 | Olutasidenib | 1 / 2 | Completed | 1 |